{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidg2a7yz44onjj5enougtdji74t3hu2bt4xy6vhfimejpm24den4a",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjmddp5jpn62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic6dj57yhehxbv52ynziuzdhz7znphpyni3c3xg45g6kk6w5wxly4"
    },
    "mimeType": "image/jpeg",
    "size": 66836
  },
  "path": "/2026/04/16/roche-elevidys-pivotal-trial-europe-sarepta/?utm_campaign=rss",
  "publishedAt": "2026-04-16T10:32:07.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "drug development",
    "Pharmaceuticals",
    "rare disease",
    "STAT+"
  ],
  "textContent": "Roche is launching a Phase 3 trial of the controversial Duchenne gene therapy Elevidys, hoping it could lead to approval in Europe.",
  "title": "STAT+: Roche to launch another Elevidys trial, with eyes on European approval",
  "updatedAt": "2026-04-16T10:40:15.000Z"
}